Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy

Isobella Honeyborne, Timothy D. McHugh, Iitu Kuittinen, Anna Cichonska, Dimitrios Evangelopoulos, Katharina Ronacher, Paul D. van Helden, Stephen H. Gillespie, Delmiro Fernandez-Reyes, Gerhard Walzl, Juho Rousu, Philip D. Butcher, Simon J. Waddell^*

^*Tämän työn vastaava kirjoittaja

Tutkimustuotos: Lehtiartikkeli › Article › Scientific › vertaisarvioitu

28 Sitaatiot (Scopus)

130 Lataukset (Pure)

1 tulosta
- Nimi
- Aloituspäivä(nouseva)

Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy
Honeyborne, I. (Contributor), McHugh, T. D. (Contributor), Kuittinen, I. (Contributor), Cichonska, A. (Creator), Evangelopoulos, D. (Contributor), Ronacher, K. (Contributor), van Helden, P. D. (Contributor), Gillespie, S. H. (Contributor), Fernandez-Reyes, D. (Contributor), Walzl, G. (Contributor), Rousu, J. (Contributor), Butcher, P. D. (Contributor) & Waddell, S. J. (Contributor), figshare, 1 tammik. 2016
DOI - pysyväislinkki: 10.6084/m9.figshare.c.3628568.v1, https://figshare.com/collections/Profiling_persistent_tubercule_bacilli_from_patient_sputa_during_therapy_predicts_early_drug_efficacy/3628568/1
Tietoaineisto: Dataset

Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy

Tietoaineistot

Hakutulokset

Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy